Table 4 QLQ-TC26 scores in patients with previous metastatic or non-metastatic disease post-treatment
|  | Previous metastatic disease N = 21 | Previous non-metastatic disease N = 157 |  |  | ||
|---|---|---|---|---|---|---|
EORTC QLQ-TC26 | Mean | SD | Mean | SD | t-statistic | p-value |
Treatment Side Effects | 15.3 | 21.8 | 8.2 | 12.3 | 1.461 | 0.158 |
Treatment Satisfaction | 78.7 | 31.2 | 92.7 | 19.7 | −1.860 | 0.079 |
Future Perspective | 65.9 | 26.1 | 67.3 | 26.6 | −0.233 | 0.816 |
Family Problems | 30.0 | 34.0 | 21.4 | 29.0 | 1.218 | 0.225 |
Infertility | 30.2 | 31.5 | 29.9 | 33.8 | 0.029 | 0.977 |
Communication | 71.4 | 26.9 | 85.0 | 22.8 | −2.510 | 0.013* |
Body Image Problems | 22.2 | 32.2 | 11.3 | 20.5 | 1.520 | 0.143 |
Sexual Activity | 50.0 | 26.4 | 67.9 | 26.3 | −2.932 | 0.004** |
Sexual Functioning | 76.9 | 33.9 | 87.7 | 21.8 | −1.325 | 0.201 |
Job Education problems | 22.2 | 35.5 | 10.0 | 23.7 | 1.536 | 0.139 |
Physical limitations | 22.2 | 35.5 | 13.0 | 24.4 | 1.161 | 0.258 |
Sexual Enjoyment | 59.3 | 32.5 | 81.3 | 24.3 | −3.503 | 0.001** |
Testicular Implant Satisfaction | 66.7 | 38.5 | 66.7 | 32.9 | < 0.001 | 1.000 |